A comprehensive on-site review of your current processes is necessary to identify areas of risk.
Federal and state laws address the need for controlled substance monitoring and reporting
Much time and energy may be devoted to monitoring for drug diversion, and once suspected,
Federal and state laws address the need for controlled substance monitoring and reporting
As Rxpert Solutions’ lead consultant, Terri Vidals has years of experience in drug diversion monitoring
For many, the holidays are a time of struggle. The reason for the struggle varies. I am hoping at least one person struggling with substance
In the fast-paced world of healthcare, where decisions can have life-altering consequences, the terms “accountability” and “responsibility” often get thrown around interchangeably. However, these two
Health Care Diversion
https://healthcarediversion.org
DEA Office of Diversion Control
https://www.deadiversion.usdoj.gov/
International Health Facility Diversion Association
https://ihfda.org/
Opioid prescribing
https://www.teaterhs.com/
Maureen Burger, MSN, RN, CPHQ, FACHE
Chief Nursing Officer at Visante
The Drug Diversion Triad gives us a better look at the elements that should be considered when assessing for diversion risk. Facilities can use this information to examine areas where they can have some control and maximize the opportunities for intervention. Listen in as two experienced diversion specialists discuss the triad and share their insights.
Terri has been a pharmacist for over 30 years and is a drug diversion mitigation and monitoring subject matter expert. Her years of experience in various roles within hospital pharmacy have given her real-world insight into risk, compliance, and regulatory requirements, as well as best practices for medication and patient safety.
Subscribe to Drug Diversion Insights with Terri Vidals to learn more about diversion mitigation.
© Copyright 2023. All Rights Reserved.